|
It's time for Merck to Pay
It's time for Merck to pay for Murder! 19 y
More people died from vioxx then on 911. Allowing Merck to put vioxx back into the market is as insane as giving more planes to terrorist to fly into buildings. It's time for reckoning day, "Merck" will be running free to kill more people and now we have a president who is protecting them. This is too insane to be allowed!
This will be a running journal of factual news as it evolves. People are welcome to contact me at anytime. I still want thier stories for my new book.
FDA Scientist Questions Need for COX-2 Drugs
By Susan Heavey and Lisa Richwine
WASHINGTON (Reuters) Feb 17 - A veteran U.S. Food and Drug Administration scientist on Thursday said he saw no need for COX-2 inhibitors, citing increased vascular risks.
The FDA, which has come under fire in recent months as being slow to respond to serious side effects of drugs, is asking an advisory panel if COX-2 inhibitors offer enough benefits to stay on the market, if they need stronger warnings, and if further research is needed.
Graham said he saw a ”class effect” of heart risk from the COX-2 in ... read more Merck will get away with Murder if this blog doesn't contine. So my book will continue until Merck hears it! This will be a contious update of the world of Merck & all pharmaceutical companies. 19 y
There has never been a time in my life on this planet that I personally have witnessed the growth of pure evil presenting itself as a form of helping people! More people died from taking the drug vioxx, then on 911! It's time America declared war on all it's enemies. Merck is being protected with the bill Bush signed. Just like Osama Bin Laden is running free...so will Merck until people put a stop to it.
By Susan Heavey and Lisa Richwine
WASHINGTON (Reuters) Feb 17 - A veteran U.S. Food and Drug Administration scientist on Thursday said he saw no need for COX-2 inhibitors, citing increased vascular risks.
The presentation by David Graham, associate director for science and medicine at the FDA's Office of Drug Safety, came on the second day of an unusual three-day meeting called by the FDA after Merck & Co. pulled Vioxx (rofecoxib) from the market in late September. The recall was prompted by a study showing the drug doubled the risk of MI and stroke.
The FDA, which has come un
FDA Scientist Questions Need for COX-2 Drugs
By Susan Heavey and Lisa Richwine
WASHINGTON (Reuters) Feb 17 - A veteran U.S. Food and Drug Administration scientist on Thursday said he saw no need for COX-2 inhibitors, citing increased vascular risks.
The presentation by David Graham, associate director for science and medicine at the FDA’s Office of Drug Safety, came on the second day of an unusual three-day meeting called by the FDA after Merck & Co. pulled Vioxx (rofecoxib) from the market in late September. The recall was prompted by a study showing the drug doubled the risk of MI ... read more |